Rani Therapeutics Holdings

NasdaqGM:RANI Stock Report

Mkt Cap: US$454.2m

Rani Therapeutics Holdings Past Performance

How has Rani Therapeutics Holdings performed over the past 5 years?

Past Performance Score


Past Performance Score 0/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


Last years revenue growth

Earnings and Revenue History

Quality Earnings: RANI is currently unprofitable.

Growing Profit Margin: RANI is currently unprofitable.

Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if RANI's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Unable to compare RANI's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: RANI is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (5%).

Return on Equity

High ROE: RANI has a negative Return on Equity (-72.78%), as it is currently unprofitable.

Discover strong past performing companies